Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.16.85 CHF
Change Today +0.15 / 0.90%
Volume 11.0K
LIFE On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
As of 11:43 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

lifewatch ag-reg (LIFE) Snapshot

Open
SFr.16.20
Previous Close
SFr.16.70
Day High
SFr.16.95
Day Low
SFr.16.20
52 Week High
06/2/15 - SFr.17.30
52 Week Low
08/8/14 - SFr.7.78
Market Cap
226.6M
Average Volume 10 Days
13.4K
EPS TTM
SFr.-0.81
Shares Outstanding
13.4M
EX-Date
02/8/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LIFEWATCH AG-REG (LIFE)

Related News

No related news articles were found.

lifewatch ag-reg (LIFE) Related Businessweek News

No Related Businessweek News Found

lifewatch ag-reg (LIFE) Details

LifeWatch AG develops, manufactures, and sells wireless healthcare and wellness related technologies and systems in the United States, Canada, Europe, Asia, and internationally. It operates through Sales of Systems, Mobile Health, and Services segments. The company offers atrial fibrillation patient care service for remote monitoring of patients post-ablation; LifeStar ambulatory cardiac telemetry (ACT) for use in electrocardiogram (ECG) monitoring; stroke patient care management service, which helps in the monitoring of stroke in patients; and the NiteWatch home sleep testing service that is used for the sleep monitoring of patients with suspected Obstructive Sleep Apnea disease. It also provides event and Holter monitors including, LifeStar AF express auto-detect looping monitor that records the heart rhythm and saves the pre-event portion of the ECG; Explorer looping monitor, which records a patient's ECG; and Micro ER non-looping event monitors that records and stores 32 seconds of real-time ECG. In addition, the company offers LifeStar ACT Ex Holter, an in-depth arrhythmia diagnosis and management solution; and the Digitrack Plus digital Holter, which provides diagnostic 3-channel ECG recording for 48 hours. Further, it offers telehealth products, such as CG-2100 personal 1-lead trans-telephonic ECG transmitter that records ECG waveforms; SelfCheck ECG, a personal 1- and 12- lead ECG event monitor; CG-7000DX BT, a diagnostic ECG recorder; CG-7000DX, a portable 12-lead ambulatory electrocardiograph; CG-6106 personal 1-lead ECG monitor, which updates the ECG waveform of the previous minutes in its memory buffer; CG-900P that measures fetal heart rate and uterine contractions, as well as allows data entry of maternal parameters; and CG-7100 personal 12-lead ECG recorder. The company was formerly known as Card Guard AG and changed its name to LifeWatch AG in May 2009. LifeWatch AG was incorporated in 2001 and is headquartered in Neuhausen am Rheinfall, Switzerland.

580 Employees
Last Reported Date: 03/31/15
Founded in 2001

lifewatch ag-reg (LIFE) Top Compensated Officers

Chief Executive Officer and Interim President...
Total Annual Compensation: SFr.477.0K
Compensation as of Fiscal Year 2014.

lifewatch ag-reg (LIFE) Key Developments

LifeWatch AG Receives CE Marking for Continuous Vital Signs Monitoring

LifeWatch AG announced that it has received CE Marking of Conformity for its continuous Vital Signs Monitoring Service. The wireless, patch-based vital signs monitoring system makes vital signs monitoring faster, easier and more convenient for both, patients and hospital staff. It will allow for early detection of vital sign changes and faster interventions, increased nursing efficiency and higher patient satisfaction. Vital Signs Patch is an easy-to-use cable-free sensor worn on a patient's upper chest. It is intended to be used on adult patients in a clinical environment for the continuous, non-invasive monitoring of ECG, heart rate, respiration rate, surface temperature, arterial blood oxygen saturation and body position. It will be available in two versions (with and without ECG) and is connected with an easy-to-use wireless supporting system which provides medical information and alerts remotely to hospital staff.

LifeWatch AG Files a 510(k) Application with the U.S. FDA

LifeWatch AG announced that on May 12, 2015, it filed a 510(k) application for clearance of its internally-developed LifeWatch Mobile Cardiac Telemetry patch, a 1-lead ECG system, with the U.S. Food and Drug Administration (FDA). LifeWatch will also soon be filing for CE Mark and other international clearances to enable the Company to market and provide its services globally. The LifeWatch Mobile Cardiac Telemetry patch will be the newest addition to LifeWatch's diagnostic monitoring offering, and continues to build on LifeWatch's commitment to becoming a truly global provider of remote diagnostic monitoring devices and services. Once cleared by the appropriate governmental agencies, LifeWatch will be able to provide patients with a new diagnostic monitoring patch alternative, capable of watching every heartbeat for adverse cardiac events and transmitting significant findings, in near real time, to a clinical service center for immediate follow-up. The LifeWatch Mobile Cardiac Telemetry patch also represents yet another addition to the growing family of LifeWatch patch solutions, including the previously announced Vital Signs Patch (VSP) and the partnership with Vital Connect Inc. for the integration of its patch into LifeWatch's diagnostic monitoring offering for the U.S. cardiac monitoring market. Patch technology is an easy to use, discrete and lightweight alternative to traditional recording and transmitting devices, which is more comfortable for the patient and should therefore lead to an increase in the diagnostic yield as a result of improved patient compliance.

LifeWatch AG, 2014 Earnings Call, Mar 31, 2015

LifeWatch AG, 2014 Earnings Call, Mar 31, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LIFE:SW SFr.16.85 CHF +0.15

LIFE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $53.97 USD +0.23
BioTelemetry Inc $9.18 USD -0.23
CardioComm Solutions Inc C$0.08 CAD 0.00
SHL TeleMedicine Ltd SFr.9.60 CHF +0.30
View Industry Companies
 

Industry Analysis

LIFE

Industry Average

Valuation LIFE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFEWATCH AG-REG, please visit www.lifewatch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.